Company’s 36-month beta value is 0.43.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NUWE is 0.19M, and currently, short sellers hold a 0.91% ratio of that floaft. The average trading volume of NUWE on July 24, 2024 was 265.88K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NUWE) stock’s latest price update
Nuwellis Inc (NASDAQ: NUWE)’s stock price has soared by 8.36 in relation to previous closing price of 3.83. Nevertheless, the company has seen a loss of -9.39% in its stock price over the last five trading days. globenewswire.com reported 2024-07-23 that MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update.
NUWE’s Market Performance
Nuwellis Inc (NUWE) has experienced a -9.39% fall in stock performance for the past week, with a -43.54% drop in the past month, and a -64.50% drop in the past quarter. The volatility ratio for the week is 8.15%, and the volatility levels for the past 30 days are at 19.43% for NUWE. The simple moving average for the past 20 days is -9.00% for NUWE’s stock, with a -74.76% simple moving average for the past 200 days.
NUWE Trading at -38.75% from the 50-Day Moving Average
After a stumble in the market that brought NUWE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.78% of loss for the given period.
Volatility was left at 19.43%, however, over the last 30 days, the volatility rate increased by 8.15%, as shares sank -45.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.80% lower at present.
During the last 5 trading sessions, NUWE fell by -9.39%, which changed the moving average for the period of 200-days by -88.02% in comparison to the 20-day moving average, which settled at $4.39. In addition, Nuwellis Inc saw -79.59% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NUWE
Current profitability levels for the company are sitting at:
- -1.86 for the present operating margin
- 0.57 for the gross margin
The net margin for Nuwellis Inc stands at -1.97. The total capital return value is set at -7.07. Equity return is now at value -248.18, with -143.62 for asset returns.
Based on Nuwellis Inc (NUWE), the company’s capital structure generated 0.2 points at debt to capital in total, while cash flow to debt ratio is standing at -65.89. The debt to equity ratio resting at 0.25. The interest coverage ratio of the stock is -4.75.
Currently, EBITDA for the company is -17.27 million with net debt to EBITDA at 0.04. When we switch over and look at the enterprise to sales, we see a ratio of 0.16. The receivables turnover for the company is 7.26for trailing twelve months and the total asset turnover is 1.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
In a nutshell, Nuwellis Inc (NUWE) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
